Context Therapeutics Inc. Share Price
CNTX$0.00
+0.00 (0.00%) Context Therapeutics Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Context Therapeutics Inc. Share Price Chart
$0.00
Please wait...
About Context Therapeutics Inc.
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Context Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Context Therapeutics Inc. Share Price
Can I buy Context Therapeutics Inc. shares in India?
Yes. You can buy Context Therapeutics Inc. in India by opening an international trading account.
What is the share price of Context Therapeutics Inc.?
As on 09 Feb '26, the share price of Context Therapeutics Inc. CNTX is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Context Therapeutics Inc.?
The 5 year returns of Context Therapeutics Inc. is as on 09 Feb '26.
What are the high & low stock price of Context Therapeutics Inc. today?
Context Therapeutics Inc. stock price hit a high of $0.00 and low of $0.00 as on 09 Feb '26.
What is the 52-week high and low of Context Therapeutics Inc. stock?
The 52-week high of Context Therapeutics Inc. stock is $0.00, while the 52-week low is $0.00 as on 09 Feb '26.